secwatch / observer
8-K filed November 21, 2022, 6:59 PM ET ticker KPRX CIK 0001372514
other material confidence high sentiment neutral materiality 0.65

Kiora raises $3.12M by reducing Class A warrant exercise price to $4.77, issuing new warrants

KIORA PHARMACEUTICALS INC

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

KIORA PHARMACEUTICALS INC entered into Inducement Letters with holders of the Prior Warrants (Exercising Holders) valued at approximately $3.12 million (effective 2022-11-17).

Action
entry
Agreement
equity purchase
Counterparty
holders of the Prior Warrants (Exercising Holders)
Value
approximately $3.12 million
Effective
2022-11-17
Exact text from the filing
On November 17, 2022, the Company entered into warrant exercise inducement offer letters (“Inducement Letters”) with holders of the Prior Warrants (collectively, the “Exercising Holders”) pursuant to which the holders agreed to exercise for cash all of their Class A Warrants to purchase 654,609 shares of the Company’s common stock in exchange for the Company’s agreement to issue new warrants (the “Inducement Warrants”) on substantially the same terms as the Existing Warrants, except as set forth herein, to purchase up to 654,609 shares of the Company’s common stock. The Company expects to receive aggregate gross proceeds of approximately $3.12 million from the exercise of the Existing Warrants by the Exercising Holders and the sale of the Inducement Warrants.
View on SEC.gov

Browse all material agreements →

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR
accession 0001104659-22-120486
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.